Inter J Stomatol ›› 2018, Vol. 45 ›› Issue (4): 408-413.doi: 10.7518/gjkq.2018.04.007

• Reviews • Previous Articles     Next Articles

Research development of silver nanoparticle on prevention and treatment of oral infectious disease

Liu Dan, Ren Biao, Cheng Lei.   

  1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Conservative Dentistry and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
  • Received:2017-11-27 Revised:2018-03-30 Online:2018-07-02 Published:2018-07-02
  • Supported by:
    This study was supported by Research and Development Project of International Science and Technology Cooperation and Exchange in Sichuan Province (2017HH0008).

Abstract: Silver nanoparticle is a novel antibacterial agent produced by nanotechnology research. This nanoparticle is widely used in various fields for its remarkable antibacterial effect compared with those of traditional inorganic antibacterial agents. Silver nanoparticle also presents considerable safety, lasting efficacy and a long-term antimicrobial effect. In this review, we mainly describe the antibacterial mechanism and characteristics of silver nanoparticles and related research on the prevention of infectious microbial diseases and treatment of oral cavity.

Key words: silver nanoparticle, antibacterial mechanism, oral microorganisms’, infectious disease;

CLC Number: 

  • R781

[1] Franci G, Falanga A, Galdiero S, et al.Silver nano-particles as potential antibacterial agents[J]. Mole-cules, 2015, 20(5): 8856-8874.
[2] Pal S, Tak YK, Soing JM.Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli[J]. Appl Environ Micro-biol, 2007, 73(6): 1712-1720.
[3] Cardozo VF, Oliveira AG, Nishio EK, et al.Antibac-terial activity of extracellular compounds produced by a Pseudomonas strain against methicillin-resistant Staphylococcus aureus (MRSA) strains[J]. Ann Clin Microbiol Antimicrob, 2013. doi:10.1186/1476-0711-12-12.
[4] Smekalova M, Aragon V, Panacek A, et al.Enhanced antibacterial effect of antibiotics in combination with silver nanoparticles against animal pathogens[J]. Vet J, 2016, 209: 174-179.
[5] Jena P, Mohanty S, Mallick R, et al.Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells[J]. Int J Nanomedicine, 2012, 7(9): 1805-1818.
[6] Durán N, Durán M, de Jesus MB, et al. Silver nano-particles: a new view on mechanistic aspects on an-timicrobial activity[J]. Nanomedicine, 2016, 12(3): 789-799.
[7] Perugini Biasi-Garbin R, Saori Otaguiri E, Morey AT, et al. Effect of eugenol against Streptococcus agalactiae and synergistic interaction with biolo-gically produced silver nanoparticles[J]. Evid Based Complement Alternat Med, 2015, 2015: 861497.
[8] Melo MA, Guedes SF, Xu HH, et al.Nanotechnology-based restorative materials for dental caries mana-gement[J]. Trends Biotechnol, 2013, 31(8): 459-467.
[9] Corrêa JM, Mori M, Sanches HL, et al.Silver nano-particles in dental biomaterials[J]. Int J Biomater, 2015, 2015: 485275.
[10] Imazato S.Antibacterial properties of resin com-posites and dentin bonding systems[J]. Dent Mater, 2003, 19(6): 449-457.
[11] Cheng L, Weir MD, Xu HH, et al.Antibacterial amorphous calcium phosphate nanocomposites with a quaternary ammonium dimethacrylate and silver nanoparticles[J]. Dent Mater, 2012, 28(5): 561-572.
[12] Cheng L, Zhang K, Weir MD, et al.Effects of anti-bacterial primers with quaternary ammonium and nano-silver on Streptococcus mutans impregnated in human dentin blocks[J]. Dent Mater, 2013, 29(4): 462-472.
[13] Cheng L, Weir MD, Zhang K, et al.Dental primer and adhesive containing a new antibacterial quater-nary ammonium monomer dimethylaminododecyl methacrylate[J]. J Dent, 2013, 41(4): 345-355.
[14] Shantiaee Y, Dianat S, Khani H, et al.Cytotoxicity comparison of nanosilver coated gutta-percha with guttaflow and normal gutta-percha on L929 fibro-blast with MTT assay[J]. J Dent School, 2011, 29(2): 62-68.
[15] Lotfi M, Vosoughhosseini S, Ranjkesh B, et al.An-timicrobial efficacy of nanosilver, sodium hypo-chlorite and chlorhexidine gluconate against Entero-coccus faecalis[J]. Afr J Biotechnol, 2011, 10(35): 6679-6803.
[16] Abbasipour F, Akheshteh V, Rastqar A, et al.Com-paring the effects of mineral trioxide aggregate and calcium enriched mixture on neuronal cells using an electrophysiological approach[J]. Iran Endod J, 2012, 7(2): 79-87.
[17] Samiei M, Aghazadeh M, Lotfi M, et al.Antimicro-bial efficacy of mineral trioxide aggregate with and without silver nanoparticles[J]. Iran Endod J, 2013, 8(4): 166-170.
[18] Jonaidi-Jafari N, Izadi M, Javidi P.The effects of silver nanoparticles on antimicrobial activity of pro-root mineral trioxide aggregate (MTA) and calcium enriched mixture (CEM)[J]. J Clin Exp Dent, 2016, 8(1): e22-e26.
[19] Salerno C, Pascale M, Contaldo M, et al.Candida-associated denture stomatitis[J]. Med Oral Patol Oral Cir Bucal, 2011, 16(2): e139-e143.
[20] Gendreau L, Loewy ZG.Epidemiology and etiology of denture stomatitis[J]. J Prosthodont, 2011, 20(4): 251-260.
[21] Navabi N, Gholamhoseinian A, Baghaei B, et al.Risk factors associated with denture stomatitis in healthy subjects attending a dental school in Sou-theast Iran[J]. Sultan Qaboos Univ Med J, 2013, 13(4): 574-580.
[22] Chandra J, Mukherjee PK, Leidich SD, et al.Anti-fungal resistance of candidal biofilms formed on denture acrylic in vitro[J]. J Dent Res, 2001, 80(3): 903-908.
[23] Rowan R, McCann M, Kavanagh K. Analysis of the response of Candida albicans cells to silver (Ⅰ)[J]. Med Mycol, 2010, 48(3): 498-505.
[24] Acosta-Torres LS, Mendieta I, Nuñez-Anita RE, et al.Cytocompatible antifungal acrylic resin contai-ning silver nanoparticles for dentures[J]. Int J Na-nomedicine, 2012, 7: 4777-4786.
[25] Monteiro DR, Gorup LF, Takamiya AS, et al.Silver distribution and release from an antimicrobial den-ture base resin containing silver colloidal nanopar-ticles[J]. J Prosthodont, 2012, 21(1): 7-15.
[26] Darouiche RO.Treatment of infections associated with surgical implants[J]. New Engl J Med, 2004, 350(14): 1422-1429.
[27] Schmalzried TP, Amstutz HC, Au MK, et al.Etio-logy of deep sepsis in total hip arthroplasty. The significance of hematogenous and recurrent infec-tions[J]. Clin Orthop Relat Res, 1992(280): 200-207.
[28] Zheng Y, Li J, Liu X, et al.Antimicrobial and osteo-genic effect of Ag-implanted titanium with a nano-structured surface[J]. Int J Nanomedicine, 2012, 7: 875-884.
[29] Passos SP, Gressler May L, Faria R, et al.Implant-abutment gap versus microbial colonization: clinical significance based on a literature review[J]. J Biomed Mater Res Part B Appl Biomater, 2013, 101(7): 1321-1328.
[30] Antoci V Jr, Adams CS, Parvizi J, et al.The inhi-bition of Staphylococcus epidermidis biofilm forma-tion by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infec-tion[J]. Biomaterials, 2008, 29(35): 4684-4690.
[31] Vester H, Wildemann B, Schmidmaier G, et al.Gentamycin delivered from a PDLLA coating of metallic implants: in vivo and in vitro characteri-sation for local prophylaxis of implantrelated osteo-myelitis[J]. Injury, 2010, 41(10): 1053-1059.
[32] Zhao L, Wang H, Huo K, et al.Antibacterial nano-structured titania coating incorporated with silver nanoparticles[J]. Biomaterials, 2011, 32(24): 5706-5716.
[33] Flores CY, Diaz C, Rubert A, et al.Spontaneous adsorption of silver nanoparticles on Ti/TiO2 surfaces. Antibacterial effect on Pseudomonas aeruginosa[J]. J Colloid Interface Sci, 2010, 350(2): 402-408.
[34] Matsubara VH, Igai F, Tamaki R, et al.Use of silver nanoparticles reduces internal contamination of ex-ternal hexagon implants by Candida albicans[J]. Braz Dent J, 2015, 26(5): 458-462.
[35] Tufekci E, Dixon JS, Gunsolley JC, et al.Prevalence of white spot lesions during orthodontic treatment with fixed appliances[J]. Angle Orthod, 2011, 81(2): 206-210.
[36] Sonesson M, Bergstrand F, Gizani S, et al.Manage-ment of post-orthodontic white spot lesions: an up-dated systematic review[J]. Eur J Orthod, 2017, 39(2): 116-121.
[37] Guzmán-Armstrong S, Chalmers J, Warren JJ, et al.White spot lesions: prevention and treatment[J]. Am J Orthod Dentofacial Orthop, 2010, 138(6): 690-696.
[38] Wang X, Wang B, Wang Y.Antibacterial orthodon-tic cement to combat biofilm and white spot lesions[J]. Am J Orthod Dentofacial Orthop, 2015, 148(6): 974-981.
[39] Metin-Gürsoy G, Taner L, Akca G.Nanosilver coa-ted orthodontic brackets: in vivo antibacterial proper-ties and ion release[J]. Eur J Orthod, 2017, 39(1): 9-16.
[40] Abadi MF, Mehrabian S, Asghari B, et al. Silver nanoparticles as active ingredient used for alcohol-free mouthwash[J]. GMS Hyg Infect Control, 2013, 8(1): Doc05.
[41] Yang JY, Huang CY, Chuang SS, et al.A clinical experience of treating exfoliative wounds using na-nocrystalline silver-containing dressings (Acti-coat)[J]. Burns, 2007, 33(6): 793-797.
[1] Yang Xiaoyu, Yang Tao, Liu Changhong, Huang Chengwei, Li Shiyi. Preliminary study on the mechanism of antimicrobial activity of peptide P9-0 on pathogens causing oral infection [J]. Inter J Stomatol, 2015, 42(3): 276-280.
Full text



[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[7] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[8] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[9] . [J]. Inter J Stomatol, 2008, 35(S1): .
[10] . [J]. Inter J Stomatol, 2008, 35(S1): .